NIHR Alder Hey Clinical Research Facility
This £2.6million NIHR-funded facility, opened in September 2012, seeks to improve the health and well-being of children by providing an internationally excellent facility for conducting experimental medicine and early phase studies. The facility is staffed by an expert team, which enables the safe delivery of high intensity, complex research studies of new medications and interventions, including those requiring inpatient, overnight care. It is an important “one-stop” resource for the commercial sector, including pharmaceutical companies, for the conduct of experimental medicine and early phase studies of novel agents under the EU Regulation on Better Medicines for Children.
MRC Centre for Drug Safety Science
The MRC CDSS undertakes clinical and basic research into the causes, characteristics, and consequences of adverse drug reactions (ADRs) to understand the fundamental mechanisms behind them. This facilitates safer drug design and provides pharmacological rationale for the safer use of medicines in patients.
Clinical Trials Research Centre at the University of Liverpool
The CTRC supports phase I-IV multi centre randomised controlled trials, systematic reviews, core outcome sets, service evaluation, and other research and has a specialised paediatrics unit.
MRC North West Hub for Trials Methodology Research (NWHTMR)
NWHTMR is a collaboration between the Universities of Liverpool, Lancaster, Bangor, and Manchester. One of the Hub’s three main research themes is early phase trial design. Continued development focuses on novel model-based designs for early phase trials of medicines for children, and the extent to which extrapolation of efficacy and safety data from adults to children can be undertaken.
NIHR Biomedical Research Centre, Moorfield’s Eye Hospital and UCL-Institute of Ophthalmology
The NIHR Biomedical Research Centre is a partnership between Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology. The primary purpose of the centre is to conduct 'translational research' that is designed to take advances in basic medical research from the laboratory to the clinic, enabling patients to benefit more quickly from new scientific breakthroughs.
Clinical Academic Department of Paediatric Rheumatology at Alder Hey
Liverpool is one of the UK’s leading paediatric rheumatology research centres, combining access to large clinical cohorts of all EATC disease themes, key clinical strengths in diagnosis, and multidisciplinary management with leadership of major collaborative research programmes.
Department of Clinical Pharmacy, Alder Hey
The Department of Pharmacy supports a large portfolio of commercial & non-commercial CTIMPs and is an integral part of supporting the portfolios of the NIHR Children’s Speciality and the Children and Children’s Cancer & Leukaemia Group. The NIHR Alder Hey Clinical Research Facility has a dedicated dispensary and senior pharmacist expertise, including within the aseptic suite. The inpatient pharmacy unit includes provision for a gene therapy suite. The Paediatric Medicines Research Unit has a dedicated research team leading on programmes of research into drug safety science and age appropriate formulations.
Clinical Laboratory Medicine at Alder Hey
Alder Hey laboratories are staffed by a specialist team of scientific, technical and support staff, supported by membership of professional bodies (e.g. Institute of Biomedical Science; Royal College of Pathologists; Association for Clinical Biochemistry). The laboratory is equipped with ‘state-of-the-art’ instrumentation supporting both sample throughput and developmental research, including high specification separation technology, such as tandem mass spectrometry. This ensures extensive in-house assay capability and capacity, commensurate with the requirements of the EATC. The laboratories accommodate staff dedicated to processing research samples and interpretation of results.
The Innovation Hub is a dedicated 1,000m2 space within Alder Hey in the Park. The innovation team is forging relationships with industry, academia, and healthcare professionals with a shared mission to drive the best of new technology into healthcare.